NEWS
Final bids due for Device Tech in takeover pitch
SYDNEY: Pemba Capital Partners has asked suitors for its medical supplies business, Device Technologies, to… read more
Hope for regenerative medicine bonanza now emerging
MELBOURNE: Regenerative medicine could be worth $6 billion in annual revenue and 6000 new jobs… read more
Life insurers retreat from genetic testing disclosure
SYDNEY: The life insurance industry has backflipped on its genetic testing policy and will allow… read more
